Open AccessAssessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs
Publication year - 2017
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000006958
Subject(s) - medicine , ribavirin , hepatocellular carcinoma , interferon , pegylated interferon , virology , gastroenterology , oncology , pharmacology , hepatitis c virus , virus